doi: 10.1016/s0145-2126(99)00040-5.
Augmentation of methylprednisolone-induced differentiation of myeloid leukemia cells by serine/threonine protein phosphatase inhibitors
Affiliations
- PMID: 10374865
- DOI: 10.1016/s0145-2126(99)00040-5
Item in Clipboard
Augmentation of methylprednisolone-induced differentiation of myeloid leukemia cells by serine/threonine protein phosphatase inhibitors
Leuk Res.
1999 May.
Abstract
To elucidate the roles of serine/threonine protein phosphatases type 1 (PP1) and type 2A (PP2A) in methylprednisolone-induced differentiation of HL60 cells into granulocytes and K562 cells into monocytes, we examined the effect of serine/threonine protein phosphatase inhibitors, okadaic acid and Cal-A on the proliferation/differentiation of HL60 and K562 cells. Okadaic acid and Cal-A augmented methylprednisolone induced granulocytic differentiation and cell death of HL60 cells and monocytic differentiation and cell death of K562 cells in different dose ranges, respectively. These data suggest an important role of PP1 and PP2A in the mechanism leading to differentiation of leukemic cells.
Similar articles
-
Arsenic trioxide and methylprednisolone use different signal transduction pathways in leukemic differentiation.Leuk Res. 2002 Apr;26(4):391-8. doi: 10.1016/s0145-2126(01)00147-3. Leuk Res. 2002. PMID: 11839383
-
Augmentation of retinoic acid-induced granulocytic differentiation in HL-60 leukemia cells by serine/threonine protein phosphatase inhibitors.FEBS Lett. 1992 Dec 21;314(3):340-4. doi: 10.1016/0014-5793(92)81501-c. FEBS Lett. 1992. PMID: 1334850
-
Phosphorylation and activation of phosphodiesterase type 3B (PDE3B) in adipocytes in response to serine/threonine phosphatase inhibitors: deactivation of PDE3B in vitro by protein phosphatase type 2A.Biochem J. 1999 Aug 1;341 ( Pt 3)(Pt 3):839-45. Biochem J. 1999. PMID: 10417351 Free PMC article.
-
A molecular modeling analysis of the binding interactions between the okadaic acid class of natural product inhibitors and the Ser-Thr phosphatases, PP1 and PP2A.Bioorg Med Chem. 1997 Sep;5(9):1751-73. doi: 10.1016/s0968-0896(97)00145-4. Bioorg Med Chem. 1997. PMID: 9354231 Review.
-
Okadaic acid: the archetypal serine/threonine protein phosphatase inhibitor.Curr Med Chem. 2002 Nov;9(22):1939-80. doi: 10.2174/0929867023368791. Curr Med Chem. 2002. PMID: 12369865 Review.
Cited by
-
Colony-stimulating factor-1 (CSF-1) receptor-mediated macrophage differentiation in myeloid cells: a role for tyrosine 559-dependent protein phosphatase 2A (PP2A) activity.Biochem J. 2001 Sep 1;358(Pt 2):431-6. doi: 10.1042/0264-6021:3580431. Biochem J. 2001. PMID: 11513742 Free PMC article.
-
Interaction of olive oil-based propolis and caffeic acid phenethyl ester with methylprednisolone used in the treatment of human acute myeloid leukemia.Mol Biol Rep. 2024 Apr 20;51(1):559. doi: 10.1007/s11033-024-09493-7. Mol Biol Rep. 2024. PMID: 38643306
-
Cromoglycate drugs suppress eicosanoid generation in U937 cells by promoting the release of Anx-A1.Biochem Pharmacol. 2009 Jun 15;77(12):1814-26. doi: 10.1016/j.bcp.2009.03.010. Epub 2009 Mar 24. Biochem Pharmacol. 2009. PMID: 19428336 Free PMC article.
-
Deregulation of the protein phosphatase 2A, PP2A in cancer: complexity and therapeutic options.Tumour Biol. 2016 Sep;37(9):11691-11700. doi: 10.1007/s13277-016-5145-4. Epub 2016 Jul 21. Tumour Biol. 2016. PMID: 27444275 Review.
-
PP2A-Mediated Anticancer Therapy.Gastroenterol Res Pract. 2013;2013:675429. doi: 10.1155/2013/675429. Epub 2013 Nov 7. Gastroenterol Res Pract. 2013. PMID: 24307892 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
